Cargando…
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2
Background: The role of the cytokine interleukin-37 (IL-37) has been recognized in reversing inflammation-mediated metabolic costs. The aim was to evaluate the clinical utility of this cytokine as a diagnostic and prognostic marker in patients with type 2 diabetes (T2D). Methods: We included 170 old...
Autores principales: | Bosnić, Zvonimir, Babič, František, Anderková, Viera, Štefanić, Mario, Wittlinger, Thomas, Majnarić, Ljiljana Trtica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966907/ https://www.ncbi.nlm.nih.gov/pubmed/36834391 http://dx.doi.org/10.3390/ijerph20043695 |
Ejemplares similares
-
Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients
por: Bosnić, Zvonimir, et al.
Publicado: (2023) -
Cross-Talk between the Cytokine IL-37 and Thyroid Hormones in Modulating Chronic Inflammation Associated with Target Organ Damage in Age-Related Metabolic and Vascular Conditions
por: Majnarić, Ljiljana Trtica, et al.
Publicado: (2022) -
Prescribing Analgesics to Older People: A Challenge for GPs
por: Majnarić, Ljiljana Trtica, et al.
Publicado: (2020) -
Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians’ Clinical Reasoning by Reducing Patients’ Complexity
por: Bosnic, Zvonimir, et al.
Publicado: (2021) -
Cardiovascular risk and aging: the need for a more comprehensive understanding
por: Trtica Majnarić, Ljiljana, et al.
Publicado: (2021)